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Background: Pseudomonas aeruginosa is a major human pathogen, which also affects animals. It is thought that
P. aeruginosa has a non-clonal epidemic population structure, with distinct isolates found in humans, animals or the
environment. However, very little is known about the structure of the P. aeruginosa population from diseased
animals. Data on antimicrobial resistance are also scarce.
Results: Thirty-four already registered and 19 new MLST profiles were identified. Interestingly, a few clones were
more prevalent, and clones associated to human outbreaks were also detected. Multidrug resistance phenotypes
were overall rare.
Conclusion: We highlight the non clonal structure of the population and show a higher prevalence of specific
clones, possibly correlating with higher pathogenicity. The low proportion of antimicrobial resistance contrasts with
the high resistance rate of human isolates.
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Pseudomonas aeruginosa is a major opportunistic human
pathogen, causing infections mostly in patients with im-
paired immune systems [1], or in people suffering from
cystic fibrosis. It is also a cause of diseases in both live-
stock and companion animals, including otitis and urinary
tract infections in dogs, mastitis in dairy cows, endometri-
tis in horses and hemorrhagic pneumoniae in fur-bearing
animals such as mink or foxes [2-4].
P. aeruginosa is naturally resistant to many classes of
drugs and its capacity to rapidly acquire resistance during
treatment is a frequent source of therapeutic failures in
humans [5]. It is generally admitted that the P. aeruginosa
population is non clonal, i.e. that population structure of P.
aeruginosa is highly diverse with a high number of clonal
groups with no or poor association between clonal groups
and ecological niches or specific diseases. Moreover, human* Correspondence: marisa.haenni@anses.fr
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unless otherwise stated.and environmental isolates are distinct, and there are no
specific clones associated with a specific habitat, disease
or animal species, except for a few multi-drug resistant
clusters (called ‘high-risks clones’) that are spreading
worldwide [6,7].
However, since the structure of the P. aeruginosa popu-
lation from animals remains unknown in France, the ob-
jective of this study was to provide a snapshot on the
genetic diversity of this bacterium, to be compared with
clones circulating in humans. In line with a possible risk
of animal-to-human transfer, susceptibility of those iso-
lates to antimicrobials used in human medicine was also
investigated.Results
A total of 68 isolates was genotyped by PFGE and 60 dif-
ferent pulsotypes (PTs) were obtained (see Additional
file 1). The eight very close PTs were shared by two or
three animals that had no epidemiological link and origi-
nated from diverse locations in France.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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than MLST, we considered that isolates with a very close
PT shared the same ST [8]. MLST was thus performed
on one isolate representative of each of the 60 PTs, lead-
ing to the identification of 53 distinct STs (http://
pubmlst.org/paeruginosa). Among them, 34 were already
registered in the MLST database while 19 were new
(ST1611-1614 and ST1708-1722). ST108, which was
represented by very close PTs in two dogs (24264/
25810), was additionally found in a cow and a horse
(26849/26185; see Additional file 2) presenting divergent
PTs. ST395 and ST1614 were represented by 3 isolates,
whereas 6 STs included 2 isolates (see Additional file 2).
The 38 remaining STs were represented by a single isolate.
Three STs, including two new profiles, were recovered in
both dogs and horses (ST155, ST1611 and ST1614).
We then determined whether the clones of P. aerugi-
nosa found in animals in France clustered on the global
dendrogram of the 1740 currently defined STs (Figure 1).
The maximum likelihood (ML) tree produced by the
alignment of the concatenated gene sequences of the
currently known STs displayed a bush-like structure
showing the non-clonal structure of the species [9]. AsFigure 1 Comparative analysis based on concatenated sequences of the s
The STs found in dogs, bovines, and horses in the present collection are represenillustrated by Figure 1, the 53 STs of our collection scat-
tered throughout the ML tree.
Finally, we investigated the antimicrobial susceptibility of
all P. aeruginosa isolates. Susceptibilities to fosfomycin, cip-
rofloxacin and gentamicin were the most frequently affected,
with 54.4%, 42.6%, and 41.2% of resistant isolates, respect-
ively (Table 1). Resistant isolates mostly came from dogs and
significant differences (p < 0.05) in resistances compared to
horses and cows were observed for ticarcillin – clavulanic
acid, gentamicin and ciprofloxacin. Multidrug resistance
(non-susceptible to three or four antimicrobial categories)
was absent in dairy cows and horses, whereas it was rela-
tively common (16/46; 35%) in dog isolates (Additional
file 2). Among these isolates, combinations of resistances
to β-lactams-aminoglycosides-fosfomycin or to β-lactams-
aminoglycosides-ciprofloxacin were the most frequently
detected. No resistance to carbapenems was observed.
Discussion
In veterinary medicine, P. aeruginosa is not a widespread
pathogen but is responsible for a variety of difficult-to-
treat infections. Our study adds data to the limited com-
prehensive picture of the population structure of clinicaleven housekeeping genes of P. aeruginosa MLST scheme (n = 1722).
ted with red, blue, and green spots, respectively.
Table 1 Antimicrobial resistance of the 68 P. aeruginosa strains
Antibiotics Breakpoints
(mm; S≥/R<)
Horses and cows (n = 22) Dogs (n = 46) Comparison of proportions











Piperacillin 18/18 0 0.0 0 0.0 .
Piperacillin-
tazobactam
19/19 0 0.0 0 0.0 .
Ticarcillin 22/22 3 13.6 11 23.9 0.5093
Ticarcillin-
clavulanic acid
22/22 1 4.5 16 34.8 0.0071
Ceftazidime 19/19 0 0.0 0 0.0 .
Cefepime 19/19 0 0.0 4 8.7 0.3817
Aztreonam 27/19 0 0.0 3 6.5 NA1
Imipenem 22/17 0 0.0 0 0.0 .
Meropenem 22/15 0 0.0 0 0.0 .
Amikacin 17/15 0 0.0 7 15.2 0.1322
Gentamicin 16/16 2 9.1 26 56.5 0.0002
Tobramycin 16/16 1 4.5 5 10.9 0.6868
Fosfomycin 14/14 15 68.2 22 47.8 0.1149
Ciprofloxacin 25/22 0 0.0 29 63.0 <0.0001
1NA: not applicable.
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genetic diversity even though 8 clones were surprisingly
not unique. Both indistinguishable and very close PFGE
profiles were also found among mink P. aeruginosa from
different regions in Eastern China [10], suggesting that
certain P. aeruginosa clones, similarly to humans, would
be more pathogenic to animals than others. These
clones may spread either through a food or water supply,
or may persist in the environment, as demonstrated for
P. aeruginosa infecting mink [4,10].
STs were also diverse with numerous new profiles (19/53).
Their scattering throughout the ML tree indicates a poor as-
sociation between an animal species and a specific subset of
the P. aeruginosa population. Kidd et al. drew similar con-
clusions from eBURST data and from the calculation of
genetic diversity index on animal isolates recovered in
Queensland (Australia) [6]. Additionally, we identified five
STs that are internationally widespread clones associated to
human outbreaks and sometimes to multi-drug resistance
phenotypes (ST27, ST155, ST253, ST395, ST560). These
specific clones were found in nine dogs (ST395, n = 3;
ST560, n = 3; ST253, n = 2; ST155, n = 1) and two horses
(ST27, n = 1; ST155, n = 1). However, only one of these ani-
mal isolates, belonging to ST395, presented a multidrug re-
sistant phenotype (see below and Additional file 2). Seven
STs (ST155, ST242, ST244, ST253, ST266, ST508 and
ST560) reported in this study were previously recovered in
animals in South East Queensland, Australia [6]. On the
contrary, two STs (ST863 and ST883) responsible foroutbreaks in Australian horses were not retrieved in our col-
lection [2].
Antimicrobial resistance was principally observed for
fosfomycin, ciprofloxacin and gentamicin, a situation that
may be explained by the frequent veterinary use of amino-
glycosides and fluoroquinolones in France, especially for
dog otitis. However, the high proportion of fosfomycin-
resistant isolates cannot be attributed to the use of this
antibiotic, which is not authorized in veterinary medicine.
Multidrug patterns were only detected in dogs, possibly
due to the fact that pets are more treated than horses and
cows, or that these animals may have been sampled after a
first treatment failure.
These data may differ from other reports in different ani-
mal species and countries [10-14], even though comparing
resistance rates obtained with different standards and sam-
pling strategies is of limited value. Of note, no carbapenem
resistance was observed here, contrary to a recent report
from a dog in China, which suggested a human-to-dog
transfer [15]. Notably, the most frequent epidemic clones as-
sociated to multidrug resistance in humans, also called
‘high-risk clones’, i.e. ST111, ST235 and ST175, were not re-
covered in our collection [8].
Conclusion
P. aeruginosa is a major human pathogen that is still poorly
documented in the veterinary field. Here, we confirm the
non-clonal epidemic structure of the P. aeruginosa popula-
tion and suggest a poor association between an animal
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seem to be more prevalent than others. We found a low
proportion of drug resistant P. aeruginosa in diseased cows
and horses, except for fosfomycin. Resistance phenotypes
were much more frequent in dogs, and multidrug resistant
P. aeruginosa seem to emerge mainly in those suffering
from otitis. However, such multidrug phenotypes are still
rare in other animal species which, at this stage, contrasts
with the high resistance rates observed in human clinical
isolates, notably to β-lactams [16]. Nevertheless, antimicro-
bial resistance in animal P. aeruginosa should be closely
monitored in the future, in line with possible animal-to-
human transfers between pets and owners. This may be es-
pecially important for patients with cystic fibrosis, which
often results from unique P. aeruginosa strains acquired in
the environment of the patient.
Methods
Isolate collection
Between 2008 and 2011, we randomly collected P. aerugi-
nosa through the Resapath, the long-term surveillance net-
work for antimicrobial resistance in pathogenic bacteria in
France (www.resapath.anses.fr). A total of 68 consecutive
and non-duplicate clinical isolates of P. aeruginosa from
dogs (n = 46), dairy cows (n = 12) and horses (n = 10) were
recovered. These isolates were mostly recovered from otitis
in dogs and mastitis in cattle (Additional file 2), and were
epidemiologically non-related since they came from different
animals, different families/farms, presented different sam-
pling dates and/or originated from different French depart-
ments. Isolates were identified by matrix-assisted laser
desorption ionization-time of flight mass spectrometry
(MALDI-TOF MS) with a Microflex LT (Bruker Daltonik
GmbH, Bremen, Germany), according to the manufacturer’s
procedure.
Genotyping
The macrorestriction (using DraI) profile of total DNA from
each isolate was determined by Pulsed-Field Gel Electro-
phoresis (PFGE), as previously described [5]. GelCompar
software was used for cluster analysis (Applied Maths,
Kortrijk, Belgium). The Dice correlation coefficients were
grouped and the UPGMA clustering algorithm was used to
depict the groups as a dendrogram. Pulsotypes (PTs) were
defined according to international recommendations [17].
Multi Locus Sequence Typing (MLST) was performed ac-
cording to the protocol of Curran et al. modified by van
Mansfeld et al. [18]. Nucleotide sequences were determined
for internal fragments of the acsA, aroE, guaA, mutL, nuoD,
ppsA, and trpE genes, on both strands, and were compared
with sequences in the P. aeruginosa MLST website (http://
pubmlst.org/paeruginosa) for the assignment of allele num-
bers and sequence types (ST). Clonal complexes (CCs) are
defined as a group of STs sharing at least 5 loci, using theSTART2 software. When two isolates presented very close
PTs (according to Tenover’s criteria), only the MLST profile
of one representative isolates was determined and then in-
ferred to the other isolates sharing the same PT.
MLST analysis
In order to build a dendrogram with the 1740 STs available
at the time of the study (including the new STs described in
this collection), we concatenated the sequences of 7 MLST
genes to form a 2,882-bp sequences alignment. We used the
Pseudomonas fluorescens Pf0-1 as the outgroup strain [19].
The best-fit nucleotide substitution model for this data was
GTR + G + I, as determined with jModelTest 0.1.1. Max-
imum likelihood tree was constructed with RAxML 7.2.8.
and visualized with Dendroscope 3.2.10. In every case,
1000 bootstrap repetitions gave values above 900 for most
branches.
Antimicrobial susceptibility testing
Susceptibility testing was performed by the disc diffusion
method according to the guidelines of the Antibiogram
Committee of the French Society for Microbiology (CA-
SFM; www.sfm-microbiologie.fr). Susceptibility to the
following 14 antibiotics of human interest was tested:
piperacillin (75 μg), piperacillin + tazobactam (75/10 μg),
ticarcillin (75 μg), ticarcillin + clavulanic acid (75/10 μg), cef-
tazidime (30 μg), cefepime (30 μg), imipenem (10 μg), mero-
penem (10 μg), aztreonam (30 μg), amikacin (30 μg),
gentamicin (15 μg), tobramycin (10 μg), fosfomycin (50 μg),
ciprofloxacin (5 μg). Bacteria were classified as susceptible,
intermediate or resistant according to the recommendations
and the human-specific clinical breakpoints approved by the
French Society for Microbiology. E. coli ATCC 25922 and P.
aeruginosa ATCC 27853 were used as quality controls.
Statistics
Comparisons of proportions were done using the Chi-2 test
(with Yate’s correction when needed), and the significance
level was set to 0.05.
Additional files
Additional file 1: Epidemiological data and resistance profiles of all
68 tested isolates. Additional file 1 includes a detailed description of
resistance profiles, sequence types and epidemiological data (sampling
data, geographical origin and pathology) of all studied isolates.
Additional file 2: Pulsed-Field Gel Electrophoresis (PFGE) profile of
all P. aeruginosa isolates. Additional file 2 presents the comparison of
PFGE profiles of all 68 studied strains.
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